对多巴胺受体D2对手作为视网膜抗纤维药物的调查
Ashley Y Gao1,2, Madison G Whaley1, Namita Saraf1
1Mayo Clinic, Department of Ophthalmology, Rochester, Minnesota, USA.
概括
多巴胺受体D2 (D2R) 抗剂在治疗视网膜纤维性疾病方面表现有前途. 弗鲁费纳和其他FDA批准的D2R抗剂有效地抑制了视网膜色素上皮细胞中的纤维化.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 视网膜纤维性疾病是视力丧失的重要原因之一.
- 视网膜色素上皮细胞 (RPE) 中的纤维激活有助于这些情况.
- 多巴胺受体D2 (D2R) 抗剂正在研究其治疗潜力.
研究的目的:
- 评估D2R抗剂在缓解RPE细胞纤维激活中的有效性.
- 为了确定在治疗视网膜纤维性疾病中潜在使用的强大的D2R抗剂.
主要方法:
- 治疗ARPE-19细胞的方法是用甲醇或27种D2R抗剂.
- 评估了纤维素沉积,细胞增殖,迁移和亲纤维素基因表达.
- 使用纤维内素沉积试验来选化合物.
主要成果:
- 洛沙证明了强大的,剂量依赖的纤维内素沉积的抑制.
- 甲托雷克萨特显示出极少的抑制作用.
- 弗鲁费纳被确定为最强大的D2R抗剂,在300-1000nm时抑制体外纤维化.
- 多种FDA批准的D2R抗剂有效地阻断了RPE细胞纤维化.
结论:
- D2R对抗是一种有前途的治疗策略,用于视网膜纤维化疾病.
- 经FDA批准的D2R抗剂,如fluphenazine,在RPE细胞中表现出显著的抗纤维作用.
- 对D2R对抗性的进一步研究可能会导致对视力威胁的纤维状症的新治疗方法.
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
163
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
163
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
281
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
281
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Open Angle Glaucoma: Treatment
408
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
408
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K


